Investment Summary |
|
|---|---|
| Date | 2023-12-19 |
| Target | Bonrue Bakery |
| Sector | Food |
| Investor(s) | Advantage Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Agnostic |
Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.
| DEAL STATS | # |
|---|---|
| Overall | 325 of 329 |
| Sector: Food M&A | 16 of 16 |
| Type: Growth Capital M&A Deals | 135 of 137 |
| State: Utah M&A | 11 of 11 |
| Country: United States M&A | 321 of 325 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-01 |
Austin Eastciders
Austin, Texas, United States Austin Eastciders is a beverages company which makes ciders from Apples. Austin Eastciders was founded in 2013 and is based in Austin, Texas. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-01 |
Esperance Pharmaceuticals
Baton Rouge, Louisiana, United States Esperance Pharmaceuticals is a pre-clinical stage company developing lytic peptides conjugated to both antibody drug conjugates (ADCs) and Chimeric antigen receptor (CAR) T-cell therapy to make them more effective. Esperance Pharmaceuticals was founded in 2005 and is based in Baton Rouge, Louisiana. |
Sell | - |
